NCT00176059View on ClinicalTrials.gov

Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

May 31, 2006

Conditions
Renal Failure, ChronicRenal Transplantation
Interventions
DRUG

intravenous immunoglobulins (IVIG)

PROCEDURE

kidney transplantation

Trial Locations (1)

Unknown

Department of Internal Medicine, University of Giessen, Giessen

Sponsors
All Listed Sponsors
collaborator

Heidelberg University

OTHER

collaborator

Astellas Pharma Inc

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

University of Giessen

OTHER